Suppr超能文献

一种用于分析聚 ADP-核糖基化依赖性相互作用蛋白的双功能 NAD。

A Bifunctional NAD for Profiling Poly-ADP-Ribosylation-Dependent Interacting Proteins.

机构信息

Department of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, California 90089, United States.

Department of Molecular Medicine, The Scripps Research Institute, Jupiter, Florida 33458, United States.

出版信息

ACS Chem Biol. 2021 Feb 19;16(2):389-396. doi: 10.1021/acschembio.0c00937. Epub 2021 Feb 1.

Abstract

Protein poly-ADP-ribosylation (PARylation) is a heterogeneous and dynamic post-translational modification regulated by various writers, readers, and erasers. It participates in a variety of biological events and is involved in many human diseases. Currently, tools and technologies have yet to be developed for unambiguously defining readers and erasers of individual PARylated proteins or cognate PARylated proteins for known readers and erasers. Here, we report the generation of a bifunctional nicotinamide adenine dinucleotide (NAD) characterized by diazirine-modified adenine and clickable ribose. By serving as an excellent substrate for poly-ADP-ribose polymerase 1 (PARP1)-catalyzed PARylation, the generated bifunctional NAD enables photo-cross-linking and enrichment of PARylation-dependent interacting proteins for proteomic identification. This bifunctional NAD provides an important tool for mapping cellular interaction networks centered on protein PARylation, which are essential for elucidating the roles of PARylation-based signals or activities in physiological and pathophysiological processes.

摘要

蛋白质聚 ADP-核糖基化(PARylation)是一种由各种writers、readers 和 erasers 调控的异质和动态的翻译后修饰。它参与了多种生物事件,并与许多人类疾病有关。目前,还没有开发出用于明确定义已知 readers 和 erasers 的单个 PARylated 蛋白或同源 PARylated 蛋白的 readers 和 erasers 的工具和技术。在这里,我们报告了一种双功能烟酰胺腺嘌呤二核苷酸(NAD)的生成,其特征是腺嘌呤经过重氮修饰和可点击的核糖。作为聚 ADP-核糖聚合酶 1(PARP1)催化的 PARylation 的极好底物,生成的双功能 NAD 能够进行光交联和 PARylation 依赖性相互作用蛋白的富集,用于蛋白质组学鉴定。这种双功能 NAD 为绘制以蛋白质 PARylation 为中心的细胞相互作用网络提供了重要工具,这对于阐明 PARylation 基信号或活性在生理和病理生理过程中的作用至关重要。

相似文献

10
Mechanisms governing PARP expression, localization, and activity in cells.细胞中 PARP 表达、定位和活性的调控机制。
Crit Rev Biochem Mol Biol. 2020 Dec;55(6):541-554. doi: 10.1080/10409238.2020.1818686. Epub 2020 Sep 23.

引用本文的文献

5
Discovery of PARP1-Sparing Inhibitors for Protein ADP-Ribosylation.用于蛋白质 ADP 核糖基化的 PARP1 选择性抑制剂的发现。
ACS Med Chem Lett. 2024 Oct 30;15(11):1940-1946. doi: 10.1021/acsmedchemlett.4c00395. eCollection 2024 Nov 14.

本文引用的文献

3
ELTA: Enzymatic Labeling of Terminal ADP-Ribose.ELTA:末端 ADP-核糖基的酶标记。
Mol Cell. 2019 Feb 21;73(4):845-856.e5. doi: 10.1016/j.molcel.2018.12.022. Epub 2019 Jan 31.
4
Macrodomain ADP-ribosylhydrolase and the pathogenesis of infectious diseases.巨域ADP核糖水解酶与传染病发病机制
PLoS Pathog. 2018 Mar 22;14(3):e1006864. doi: 10.1371/journal.ppat.1006864. eCollection 2018 Mar.
5
Proteomic Analysis of the Downstream Signaling Network of PARP1.PARP1下游信号网络的蛋白质组学分析
Biochemistry. 2018 Jan 30;57(4):429-440. doi: 10.1021/acs.biochem.7b01022. Epub 2018 Jan 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验